[1]
|
NCD Risk Factor Collaboration (NCD-RisC) (2017) Worldwide Trends in Blood Pressure from 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies with 19.1 Million Participants. The Lancet, 389, 37-55.
|
[2]
|
Yang, L., Drake, B.F. and Colditz, G.A. (2016) Obesity and Other Cancers. Journal of Clinical Oncology, 34, 4231-4237.
https://doi.org/10.1200/JCO.2016.68.4837
|
[3]
|
Choe, E.K., Kang, H.Y., Lee, Y., et al. (2018) Longitudinal As-sociations between Abdominal Obesity and Lung Function Using a Linear Mixed Model. PLOS ONE, 13, e0193516.
|
[4]
|
Elbehairy, A.F., Faisal, A., Mcisaac, H., et al. (2021) Mechanisms of Orthopnoea in Patients with Advanced COPD. European Respiratory Journal, 57, Article ID: 2000754. https://doi.org/10.1183/13993003.00754-2020
|
[5]
|
Donnell, D.E., et al. (2013) When Obesity and COPD Collide: Physiological and Clinical Consequences. Annals of the American Thoracic Society, 11, 635-644.
|
[6]
|
Turi, B.C., Codogno, J.S., Fernandes, R.A., et al. (2016) Low Levels of Physical Activity and Metabolic Syndrome: Cross-Sectional Study in the Brazilian Public Health Care System. Ciência & Saúde Coletiva, 21, 1043-1050.
https://doi.org/10.1590/1413-81232015214.23042015
|
[7]
|
Borst, V.D., et al. (2016) The Prevalence of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease, 13, 399-406.
|
[8]
|
Elliot, J.G., Donovan, G.M., Wang, K.C., et al. (2019) Fatty Airways: Implica-tions for Obstructive Disease. European Respiratory Journal, 54, Article ID: 1900857. https://doi.org/10.1183/13993003.00857-2019
|
[9]
|
Schweitzer, L., Geisler, C., Johannsen, M., et al. (2017) As-sociations between Body Composition, Physical Capabilities and Pulmonary Function in Healthy Older Adults. Euro-pean Journal of Clinical Nutrition, 71, 389-394.
|
[10]
|
Goossens, G.H. (2008) The Role of Adipose Tissue Dysfunction in the Pathogenesis of Obesity-Related Insulin Resistance. Physiology & Behavior, 94, 206-218. https://doi.org/10.1016/j.physbeh.2007.10.010
|
[11]
|
Ogawa, E. (2009) Body Mass Index in Male Patients with COPD: Correlation with Low Attenuation Areas on CT. Thorax, 64, 20-25. https://doi.org/10.1136/thx.2008.097543
|
[12]
|
Martin, M., Almeras, N., Després, J., et al. (2017) Ectopic Fat Ac-cumulation in Patients with COPD: An ECLIPSE Substudy. International Journal of Chronic Obstructive Pulmonary Disease, 12, 451-460.
https://doi.org/10.2147/COPD.S124750
|
[13]
|
Moualla, M., Qualls, C., Arynchyn, A., et al. (2017) Rapid Decline in Lung Function Is Temporally Associated with Greater Metabolically Active Adiposity in a Longitudinal Study of Healthy Adults. Thorax, 72, 1113-1120.
https://doi.org/10.1136/thoraxjnl-2016-209125
|
[14]
|
Oliveira, P.D., Wehrmeister, F.C., Horta, B.L., et al. (2017) Visceral and Subcutaneous Abdominal Adiposity and Pulmonary Function in 30-Year-Old Adults: A Cross-Sectional Analysis Nested in a Birth Cohort. BMC Pulmonary Medicine, 17, 157. https://doi.org/10.1186/s12890-017-0510-7
|
[15]
|
Singanayagam, A., Schembri, S. and Chalmers, J.D. (2013) Pre-dictors of Mortality in Hospitalized Adults with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society, 10, 81-89.
https://doi.org/10.1513/AnnalsATS.201208-043OC
|
[16]
|
Flynn, R., Macdonald, T.M., Chalmers, J.D., et al. (2018) The Effect of Changes to GOLD Severity Stage on Long Term Morbidity and Mortality in COPD. Respiratory Research, 19, Article No. 249.
https://doi.org/10.1186/s12931-018-0960-3
|
[17]
|
Soler-Cataluña, J.J., et al. (2005) Severe Acute Exacerbations and Mortality in Patients with Chronic Obstructive Pulmonary Disease. Thorax, 60, 925-931.
|
[18]
|
Kiyokawa, H., Hoshino, Y., Sakaguchi, K., et al. (2021) Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD. Antioxidants (Basel), 10, 1429. https://doi.org/10.3390/antiox10091429
|
[19]
|
Van Den Borst, B., Gosker, H.R., Wesseling, G., et al. (2011) Low-Grade Adipose Tissue Inflammation in Patients with Mild-to-Moderate Chronic Obstructive Pulmonary Disease. The American Journal of Clinical Nutrition, 94, 1504-1512. https://doi.org/10.3945/ajcn.111.023911
|
[20]
|
Schoettl, T., et al. (2018) Heterogeneity of Adipose Tissue in Development and Metabolic Function. The Journal of Experimental Biology, 221, jeb162958. https://doi.org/10.1242/jeb.162958
|
[21]
|
Buch, A., Carmeli, E., Boker, L.K., et al. (2016) Muscle Function and Fat Content in Relation to Sarcopenia, Obesity and Frailty of Old Age—An Overview. Experimental Gerontology, 76, 25-32.
https://doi.org/10.1016/j.exger.2016.01.008
|
[22]
|
Heindel, J.J., Blumberg, B., Cave, M., et al. (2016) Metabolism Disrupting Chemicals and Metabolic Disorders. Reproductive Toxicology, 68, 3-33. https://doi.org/10.1016/j.reprotox.2016.10.001
|
[23]
|
Ali Assad, N. and Sood, A. (2012) Leptin, Adiponectin and Pulmonary Diseases. Biochimie, 94, 2180-2189.
https://doi.org/10.1016/j.biochi.2012.03.006
|
[24]
|
Hornung, F., Rogal, J., Loskill, P., et al. (2021) The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections. International Journal of Molecular Sciences, 22, 3456.
https://doi.org/10.3390/ijms22073456
|
[25]
|
Creutzberg, E.C., Wouters, E.F., Vanderhoven-Augustin, I.M., et al. (2000) Disturbances in Leptin Metabolism Are Related to Energy Imbalance during Acute Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 162, 1239-1245. https://doi.org/10.1164/ajrccm.162.4.9912016
|
[26]
|
Bantulà, M., Roca-Ferrer, J., Arismendi, E., et al. (2021) Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation. Journal of Clinical Medicine, 10, 169. https://doi.org/10.3390/jcm10020169
|
[27]
|
Bruno, A., Chanez, P., Chiappara, G., et al. (2005) Does Leptin Play a Cytokine-Like Role within the Airways of COPD Patients? European Respiratory Journal, 26, 398-405. https://doi.org/10.1183/09031936.05.00092404
|
[28]
|
Bianco, A., Mazzarella, G., Turchiarelli, V., et al. (2013) Adiponectin: An Attractive Marker for Metabolic Disorders in Chronic Obstructive Pulmonary Disease (COPD). Nutrients, 5, 4115-4125. https://doi.org/10.3390/nu5104115
|
[29]
|
Dicker, A.J., Huang, J.T.J., Lonergan, M., et al. (2021) The Sputum Microbiome, Airway Inflammation, and Mortality in Chronic Obstructive Pulmonary Disease. Journal of Allergy and Clinical Immunology, 147, 158-167.
https://doi.org/10.1016/j.jaci.2020.02.040
|
[30]
|
Miller, M., Cho, J.Y., Pham, A., et al. (2009) Adiponectin and Functional Adiponectin Receptor 1 Are Expressed by Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease. The Journal of Immunology, 182, 684-691.
https://doi.org/10.4049/jimmunol.182.1.684
|
[31]
|
Soler-Cataluna, J.J., Martinez-Garcia, M.A., Sanchez, P.R., et al. (2006) Severe Acute Exacerbations and Mortality in Patients with Chronic Obstructive Pulmonary Disease: Thorax 2005; 60: 925-31. Respiratory Medicine: COPD Update, 1, 104. https://doi.org/10.1016/j.rmedu.2006.01.020
|
[32]
|
Barnes, P.J. (2016) Inflammatory Mechanisms in Patients with Chronic Obstructive Pulmonary Disease. Journal of Allergy and Clinical Immunology, 138, 16-27. https://doi.org/10.1016/j.jaci.2016.05.011
|
[33]
|
Yan, J. and Horng, T. (2020) Lipid Metabolism in Regulation of Macrophage Functions. Trends in Cell Biology, 30, 979-989. https://doi.org/10.1016/j.tcb.2020.09.006
|